Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 561
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07405346 | A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy | ||
| NCT07657403 | CONNEctome-guided Navigation for Eloquent-area Tumor Surgery Trial | ||
| NCT01413269 | Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery | ||
| NCT05587452 | Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence | ||
| NCT02815007 | Chidamide With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer | ||
| NCT06411457 | SHR-A1811 in Combination With Adebrelimab for the Treatment of HER2 Low-expressing Metastatic Breast Cancer | ||
| NCT06202001 | Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients | ||
| NCT07339839 | Glecirasib Combined With Ivonescimab for First-line Treatment of KRAS G12C-mutated NSCLC | ||
| NCT06185400 | RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations | ||
| NCT06492629 | Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma | ||
| NCT03381430 | Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR | ||
| NCT06405295 | Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation | ||
| NCT06078930 | Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms | ||
| NCT06848842 | Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases | ||
| NCT07298239 | An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC) | ||
| NCT06178601 | A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma | ||
| NCT04972201 | A Proof of Concept Study of Pan-cancer Early Detection by Liquid Biopsy | ||
| NCT07141771 | An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing | ||
| NCT06598839 | Immuno-effect of Tα1 for Stage I NSCLC | ||
| NCT05983107 | Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer | ||
| NCT03714490 | MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer | ||
| NCT04821843 | Neoadjuvant Treatment Modalities in Esophageal Cancer | ||
| NCT07200947 | A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer. | ||
| NCT07186855 | Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC | ||
| NCT03398941 | The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, Multicenter Clinical Trial | ||
| NCT06750861 | QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC | ||
| NCT07373951 | Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis | ||
| NCT01918241 | Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia | ||
| NCT02540850 | CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population | ||
| NCT07686796 | Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial | ||
| NCT04498793 | Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer | ||
| NCT05289726 | Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105 | ||
| NCT04822792 | Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT | ||
| NCT03298204 | Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01 | ||
| NCT03349762 | Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery | ||
| NCT05894889 | Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC | ||
| NCT06202014 | Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC | ||
| NCT04571476 | Diagnostic Value of UTB and TB for PPL | ||
| NCT04500717 | Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene Mutation | ||
| NCT06416930 | Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma | ||
| NCT06342336 | HS-IT101 Injection in the Treatment of Advanced Solid Tumors | ||
| NCT07533825 | Laparoscopic Staging for Stage III Gastric Cancer | ||
| NCT07657585 | CIB In Vivo CAR-T Lentiviral Injection in Patients With Advanced Malignant Tumors | ||
| NCT04099589 | Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma | ||
| NCT07514897 | Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring | ||
| NCT06615466 | Super-Hypofractionated Partial Breast Irradiation | ||
| NCT01492556 | Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer | ||
| NCT06955156 | Trilaciclib Combined With Anti-PD-1 Antibody and Chemotherapy in the Treatment of Locally Advanced TNBC | ||
| NCT06509022 | Longitudinal Study on the Evolution Trend and Influencing Factors of Postoperative Reflux of Esophageal Cancer Based on PEPTEST Technique | ||
| NCT07352280 | Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer |
